Skip to main content
. Author manuscript; available in PMC: 2020 Jul 2.
Published in final edited form as: Cell Rep. 2020 Mar 3;30(9):2989–3003.e6. doi: 10.1016/j.celrep.2020.02.040

Figure 7. ILCs Are Increased in the Pericardial Fluid from Patients with Pericarditis.

Figure 7.

(A) Gating strategy of ILCs in human pericardial fluid samples by CyTOF. L/D, live/dead.

(B) Representative CyTOF plots showing ILCs in the pericardial fluid from controls and patients with cardiac diseases. ARVC, arrhythmogenic right ventricular cardiomyopathy; IHD, ischemic heart disease.

(C) Frequency of ILCs in the pericardial fluid.

(D) Flow cytometry plots showing Lin−CD127+ ILCs in the pericardial fluid from controls and patients with pericarditis. Plots show a CD45+CD11b−CD3−CD19−CD56− population. Lin included CD1a, CD11c, CD14, CD34, CD123, CD303a(BDCA2), TCRαβ, and FcεRIα.

Concatenated samples (control, n = 3; pericarditis, n = 2) are shown in (D). One-way ANOVA followed by Tukey’s post hoc test (C) was used for statistical analysis. ***p < 0.001.